Dihydrogalanthamine (hydrobromide)
Dihydrogalanthamine hydrobromide is an acetylcholinesterase inhibitor. Dihydrogalanthamine hydrobromide can be used in research on neurological diseases such as sequelae of poliomyelitis and myasthenia gravis[1].
Product Specifications
CAS Number
69353-21-5
UNSPSC
12352005
Hazard Statement
H301-H311-H331
Target
Cholinesterase (ChE)
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
OC1C=C2CCN(CC3=CC=C(C4=C3C2C(C1)O4)OC)C.Br
Molecular Formula
C17H22BrNO3
Molecular Weight
368.27
Precautions
P260-P264-P270-P271-P280-P302+P352-P304+P340-P330-P361-P363-P405-P501
References & Citations
[1]Mroczek T. Highly efficient, selective and sensitive molecular screening of acetylcholinesterase inhibitors of natural origin by solid-phase extraction-liquid chromatography/electrospray ionisation-octopole-orthogonal acceleration time-of-flight-mass spectrometry and novel thin-layer chromatography-based bioautography. J Chromatogr A. 2009 Mar 20;1216 (12) :2519-28.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
